| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tight Junctions | 20 | 2024 | 153 | 3.950 |
Why?
|
| Colitis, Ulcerative | 16 | 2025 | 800 | 1.990 |
Why?
|
| Calcium | 17 | 2024 | 1175 | 1.820 |
Why?
|
| Colonic Pouches | 5 | 2025 | 97 | 1.670 |
Why?
|
| Intestinal Mucosa | 22 | 2021 | 824 | 1.550 |
Why?
|
| Colon | 15 | 2025 | 540 | 1.480 |
Why?
|
| Claudins | 10 | 2024 | 34 | 1.350 |
Why?
|
| Sodium-Calcium Exchanger | 11 | 2013 | 21 | 1.340 |
Why?
|
| Epithelial Cells | 11 | 2018 | 700 | 1.250 |
Why?
|
| Inflammatory Bowel Diseases | 9 | 2025 | 646 | 1.240 |
Why?
|
| Zonula Occludens-1 Protein | 8 | 2020 | 70 | 1.240 |
Why?
|
| Proctocolectomy, Restorative | 5 | 2025 | 115 | 1.170 |
Why?
|
| Atrial Fibrillation | 5 | 2024 | 419 | 1.150 |
Why?
|
| Occludin | 8 | 2020 | 66 | 1.020 |
Why?
|
| Crohn Disease | 8 | 2025 | 808 | 1.000 |
Why?
|
| Claudin-2 | 2 | 2017 | 10 | 0.990 |
Why?
|
| Membrane Proteins | 12 | 2014 | 1260 | 0.840 |
Why?
|
| Transcriptome | 3 | 2025 | 760 | 0.840 |
Why?
|
| T-Box Domain Proteins | 3 | 2019 | 127 | 0.770 |
Why?
|
| Colitis | 8 | 2018 | 261 | 0.660 |
Why?
|
| Ion Channels | 3 | 2024 | 256 | 0.640 |
Why?
|
| Colonic Neoplasms | 9 | 2016 | 579 | 0.630 |
Why?
|
| Heart Rate | 2 | 2020 | 508 | 0.630 |
Why?
|
| Atrioventricular Node | 1 | 2020 | 38 | 0.620 |
Why?
|
| Epithelium | 5 | 2024 | 315 | 0.620 |
Why?
|
| Tumor Necrosis Factor-alpha | 6 | 2018 | 688 | 0.600 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 2 | 2019 | 29 | 0.600 |
Why?
|
| Mutant Proteins | 2 | 2019 | 98 | 0.590 |
Why?
|
| Mice | 39 | 2024 | 12233 | 0.590 |
Why?
|
| Animals | 54 | 2024 | 28041 | 0.580 |
Why?
|
| Transcription Factors | 4 | 2024 | 1690 | 0.570 |
Why?
|
| Myocytes, Cardiac | 6 | 2020 | 313 | 0.570 |
Why?
|
| Sodium | 7 | 2013 | 329 | 0.520 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2020 | 210 | 0.510 |
Why?
|
| Biological Transport | 2 | 2015 | 399 | 0.480 |
Why?
|
| Organoids | 3 | 2022 | 76 | 0.470 |
Why?
|
| Myosin-Light-Chain Kinase | 3 | 2010 | 38 | 0.450 |
Why?
|
| Humans | 72 | 2025 | 93615 | 0.450 |
Why?
|
| Muscle Cells | 3 | 2002 | 16 | 0.430 |
Why?
|
| Forkhead Transcription Factors | 6 | 2021 | 174 | 0.420 |
Why?
|
| Mice, Inbred C57BL | 19 | 2023 | 3430 | 0.390 |
Why?
|
| Colectomy | 2 | 2025 | 192 | 0.390 |
Why?
|
| Gastric Mucosa | 1 | 2013 | 70 | 0.390 |
Why?
|
| Pancreatic Neoplasms | 4 | 2023 | 715 | 0.380 |
Why?
|
| Inflammation | 8 | 2023 | 1049 | 0.360 |
Why?
|
| Cell Proliferation | 7 | 2021 | 1735 | 0.360 |
Why?
|
| Heart Failure | 6 | 2024 | 1388 | 0.360 |
Why?
|
| Adenoma | 2 | 2016 | 258 | 0.340 |
Why?
|
| Myocardium | 4 | 2002 | 570 | 0.340 |
Why?
|
| Permeability | 7 | 2021 | 143 | 0.340 |
Why?
|
| Patch-Clamp Techniques | 6 | 2017 | 378 | 0.340 |
Why?
|
| Adenocarcinoma | 5 | 2019 | 1173 | 0.330 |
Why?
|
| Cholangitis, Sclerosing | 2 | 2023 | 54 | 0.320 |
Why?
|
| Sarcoplasmic Reticulum | 6 | 2019 | 25 | 0.310 |
Why?
|
| Interleukin-13 | 1 | 2010 | 41 | 0.310 |
Why?
|
| Signal Transduction | 10 | 2023 | 3498 | 0.290 |
Why?
|
| Male | 25 | 2025 | 44578 | 0.290 |
Why?
|
| Dogs | 4 | 2017 | 634 | 0.280 |
Why?
|
| Epigenesis, Genetic | 2 | 2025 | 555 | 0.280 |
Why?
|
| Tight Junction Proteins | 2 | 2020 | 14 | 0.270 |
Why?
|
| Caco-2 Cells | 6 | 2018 | 125 | 0.270 |
Why?
|
| Toxoplasmosis | 2 | 2020 | 68 | 0.270 |
Why?
|
| Toxoplasma | 2 | 2020 | 114 | 0.260 |
Why?
|
| Colorectal Neoplasms | 4 | 2023 | 1054 | 0.260 |
Why?
|
| Interleukin-10 | 4 | 2016 | 163 | 0.260 |
Why?
|
| Disease Models, Animal | 11 | 2021 | 2491 | 0.260 |
Why?
|
| Case-Control Studies | 4 | 2025 | 1933 | 0.260 |
Why?
|
| Gene Regulatory Networks | 3 | 2024 | 317 | 0.260 |
Why?
|
| Antineoplastic Agents | 4 | 2023 | 2302 | 0.250 |
Why?
|
| Middle Aged | 17 | 2025 | 27621 | 0.250 |
Why?
|
| Female | 24 | 2025 | 48779 | 0.240 |
Why?
|
| Hemangioma, Cavernous, Central Nervous System | 2 | 2020 | 259 | 0.230 |
Why?
|
| Cell Membrane | 4 | 2008 | 661 | 0.230 |
Why?
|
| Action Potentials | 5 | 2003 | 581 | 0.230 |
Why?
|
| Intestines | 4 | 2020 | 432 | 0.230 |
Why?
|
| Myocardial Contraction | 7 | 2016 | 188 | 0.230 |
Why?
|
| Diterpenes | 2 | 2023 | 24 | 0.220 |
Why?
|
| Models, Biological | 7 | 2017 | 1768 | 0.220 |
Why?
|
| Dysbiosis | 2 | 2016 | 91 | 0.220 |
Why?
|
| beta Catenin | 3 | 2014 | 265 | 0.220 |
Why?
|
| Young Adult | 8 | 2025 | 6938 | 0.220 |
Why?
|
| Indans | 1 | 2024 | 37 | 0.200 |
Why?
|
| Phenanthrenes | 1 | 2023 | 4 | 0.200 |
Why?
|
| Severity of Illness Index | 5 | 2025 | 1918 | 0.200 |
Why?
|
| Cell Line | 6 | 2015 | 2459 | 0.200 |
Why?
|
| Atrial Remodeling | 1 | 2024 | 22 | 0.200 |
Why?
|
| Cell Membrane Permeability | 2 | 2018 | 121 | 0.200 |
Why?
|
| Kinetics | 4 | 2017 | 1470 | 0.200 |
Why?
|
| Prodrugs | 1 | 2023 | 51 | 0.200 |
Why?
|
| Cysteine Endopeptidases | 2 | 2014 | 87 | 0.190 |
Why?
|
| Single-Cell Analysis | 1 | 2025 | 198 | 0.190 |
Why?
|
| Adult | 14 | 2025 | 27955 | 0.190 |
Why?
|
| Endocytosis | 3 | 2013 | 184 | 0.190 |
Why?
|
| Ventricular Function | 1 | 2002 | 41 | 0.190 |
Why?
|
| Homeostasis | 4 | 2020 | 460 | 0.190 |
Why?
|
| Gene Expression Profiling | 2 | 2025 | 1516 | 0.180 |
Why?
|
| Calcium Signaling | 3 | 2019 | 139 | 0.180 |
Why?
|
| Ion Transport | 4 | 2010 | 82 | 0.180 |
Why?
|
| Wnt Signaling Pathway | 2 | 2021 | 103 | 0.180 |
Why?
|
| Consensus | 1 | 2024 | 368 | 0.180 |
Why?
|
| Antibodies, Monoclonal, Humanized | 2 | 2018 | 1002 | 0.180 |
Why?
|
| Carcinoma, Adenoid Cystic | 1 | 2022 | 43 | 0.180 |
Why?
|
| Dementia | 1 | 2024 | 214 | 0.180 |
Why?
|
| Claudin-4 | 2 | 2020 | 8 | 0.180 |
Why?
|
| Kynurenine | 2 | 2020 | 23 | 0.180 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 2 | 1 | 2021 | 4 | 0.180 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2023 | 131 | 0.170 |
Why?
|
| Tryptophan | 2 | 2020 | 104 | 0.170 |
Why?
|
| Aged | 13 | 2024 | 20469 | 0.170 |
Why?
|
| Epidermal Growth Factor | 2 | 2012 | 115 | 0.170 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2022 | 81 | 0.170 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2014 | 392 | 0.170 |
Why?
|
| Cell Line, Tumor | 9 | 2023 | 2756 | 0.170 |
Why?
|
| Helicobacter Infections | 1 | 2021 | 36 | 0.170 |
Why?
|
| Artificial Intelligence | 1 | 2025 | 395 | 0.170 |
Why?
|
| Helicobacter pylori | 1 | 2021 | 36 | 0.170 |
Why?
|
| Cells, Cultured | 3 | 2021 | 2828 | 0.170 |
Why?
|
| Gastritis | 1 | 2021 | 37 | 0.170 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2001 | 53 | 0.160 |
Why?
|
| Cellular Reprogramming | 1 | 2021 | 50 | 0.160 |
Why?
|
| Plasma Cells | 1 | 2021 | 84 | 0.160 |
Why?
|
| Diet | 1 | 2023 | 460 | 0.160 |
Why?
|
| Mice, Transgenic | 6 | 2021 | 1584 | 0.160 |
Why?
|
| Stomach | 1 | 2021 | 113 | 0.160 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2020 | 85 | 0.160 |
Why?
|
| Lifting | 1 | 2020 | 12 | 0.160 |
Why?
|
| Parasites | 1 | 2020 | 11 | 0.160 |
Why?
|
| Lymph Nodes | 1 | 2024 | 548 | 0.160 |
Why?
|
| Mice, Knockout | 9 | 2021 | 2121 | 0.160 |
Why?
|
| Citrobacter rodentium | 2 | 2011 | 14 | 0.160 |
Why?
|
| Microfluidics | 1 | 2020 | 57 | 0.160 |
Why?
|
| Biomarkers, Tumor | 4 | 2016 | 1661 | 0.160 |
Why?
|
| Drug Discovery | 2 | 2022 | 113 | 0.160 |
Why?
|
| Endoscopic Mucosal Resection | 1 | 2020 | 28 | 0.160 |
Why?
|
| Alveolar Epithelial Cells | 1 | 2020 | 18 | 0.160 |
Why?
|
| Lymphocyte Activation | 2 | 2021 | 797 | 0.150 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2021 | 337 | 0.150 |
Why?
|
| Myosin Heavy Chains | 1 | 2020 | 86 | 0.150 |
Why?
|
| Carcinogenesis | 2 | 2019 | 235 | 0.150 |
Why?
|
| Connexin 43 | 1 | 2020 | 94 | 0.150 |
Why?
|
| Polyethylene Glycols | 2 | 2012 | 373 | 0.150 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2020 | 111 | 0.150 |
Why?
|
| Respiratory Mucosa | 1 | 2020 | 90 | 0.150 |
Why?
|
| Serotonin | 1 | 2020 | 209 | 0.150 |
Why?
|
| Cations, Divalent | 1 | 2019 | 34 | 0.150 |
Why?
|
| Retrospective Studies | 5 | 2025 | 10186 | 0.150 |
Why?
|
| Phosphatidylinositol 3-Kinases | 5 | 2011 | 281 | 0.150 |
Why?
|
| Phosphoproteins | 5 | 2012 | 259 | 0.150 |
Why?
|
| Clinical Trials as Topic | 1 | 2024 | 1103 | 0.150 |
Why?
|
| Actins | 3 | 2015 | 467 | 0.140 |
Why?
|
| Connexins | 1 | 2020 | 206 | 0.140 |
Why?
|
| KRIT1 Protein | 1 | 2018 | 62 | 0.140 |
Why?
|
| Janus Kinases | 1 | 2018 | 24 | 0.140 |
Why?
|
| Myosin Type II | 1 | 2018 | 50 | 0.140 |
Why?
|
| Computer Simulation | 3 | 2017 | 1119 | 0.140 |
Why?
|
| Genetic Loci | 1 | 2019 | 260 | 0.140 |
Why?
|
| Apoptosis | 3 | 2023 | 1719 | 0.140 |
Why?
|
| Allosteric Regulation | 3 | 2003 | 68 | 0.140 |
Why?
|
| Bacterial Physiological Phenomena | 1 | 2018 | 42 | 0.140 |
Why?
|
| Janus Kinase Inhibitors | 1 | 2018 | 29 | 0.140 |
Why?
|
| Asymptomatic Diseases | 1 | 2018 | 44 | 0.140 |
Why?
|
| Mixed Tumor, Malignant | 1 | 2017 | 4 | 0.130 |
Why?
|
| Calcineurin Inhibitors | 1 | 2018 | 53 | 0.130 |
Why?
|
| Carcinoma, Acinar Cell | 1 | 2017 | 12 | 0.130 |
Why?
|
| RNA, Untranslated | 1 | 2017 | 67 | 0.130 |
Why?
|
| Madin Darby Canine Kidney Cells | 1 | 2017 | 23 | 0.130 |
Why?
|
| Wound Healing | 2 | 2018 | 373 | 0.130 |
Why?
|
| Pyrazoles | 1 | 2018 | 153 | 0.130 |
Why?
|
| rho-Associated Kinases | 1 | 2018 | 161 | 0.130 |
Why?
|
| Risk Factors | 2 | 2025 | 5912 | 0.130 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2015 | 249 | 0.120 |
Why?
|
| RNA, Small Interfering | 4 | 2012 | 555 | 0.120 |
Why?
|
| Protein Binding | 4 | 2013 | 1528 | 0.120 |
Why?
|
| Protein Structure, Tertiary | 3 | 2013 | 726 | 0.120 |
Why?
|
| Pouchitis | 1 | 2017 | 57 | 0.120 |
Why?
|
| Lymphocytes | 1 | 2018 | 454 | 0.120 |
Why?
|
| Gastrointestinal Agents | 1 | 2018 | 181 | 0.120 |
Why?
|
| Dextran Sulfate | 2 | 2015 | 70 | 0.120 |
Why?
|
| Gastrointestinal Motility | 1 | 2016 | 26 | 0.120 |
Why?
|
| Butyrates | 1 | 2016 | 56 | 0.120 |
Why?
|
| Rabbits | 4 | 2013 | 613 | 0.120 |
Why?
|
| Drug Therapy, Combination | 1 | 2018 | 759 | 0.120 |
Why?
|
| Interleukin-15 | 1 | 2016 | 75 | 0.120 |
Why?
|
| Quinolones | 1 | 2016 | 57 | 0.120 |
Why?
|
| Leukemia | 1 | 2018 | 301 | 0.120 |
Why?
|
| Foundations | 1 | 2015 | 15 | 0.120 |
Why?
|
| Sequence Deletion | 2 | 2013 | 206 | 0.120 |
Why?
|
| Gene Knockdown Techniques | 2 | 2013 | 254 | 0.110 |
Why?
|
| Physiology | 1 | 2015 | 17 | 0.110 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2016 | 91 | 0.110 |
Why?
|
| Peptide Hormones | 1 | 2015 | 30 | 0.110 |
Why?
|
| Neuroendocrine Tumors | 1 | 2017 | 136 | 0.110 |
Why?
|
| Spectrum Analysis | 1 | 2015 | 119 | 0.110 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2017 | 293 | 0.110 |
Why?
|
| In Vitro Techniques | 4 | 2021 | 947 | 0.110 |
Why?
|
| Ion Channel Gating | 1 | 2017 | 302 | 0.110 |
Why?
|
| Claudin-1 | 3 | 2011 | 17 | 0.110 |
Why?
|
| DNA-Binding Proteins | 2 | 2018 | 1233 | 0.110 |
Why?
|
| Immunity, Innate | 1 | 2018 | 463 | 0.110 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2018 | 665 | 0.110 |
Why?
|
| Stomach Neoplasms | 1 | 2017 | 308 | 0.110 |
Why?
|
| Aspirin | 1 | 2015 | 167 | 0.110 |
Why?
|
| Forkhead Box Protein O3 | 5 | 2013 | 21 | 0.100 |
Why?
|
| Caveolin 1 | 2 | 2013 | 24 | 0.100 |
Why?
|
| Cell Separation | 3 | 2003 | 200 | 0.100 |
Why?
|
| Interferon Type I | 1 | 2015 | 164 | 0.100 |
Why?
|
| Cytokines | 4 | 2021 | 863 | 0.100 |
Why?
|
| Leiomyosarcoma | 1 | 2014 | 48 | 0.100 |
Why?
|
| Down-Regulation | 5 | 2013 | 523 | 0.100 |
Why?
|
| Phosphorylation | 5 | 2018 | 1130 | 0.100 |
Why?
|
| Inflammation Mediators | 1 | 2014 | 159 | 0.100 |
Why?
|
| Bifidobacterium | 1 | 2013 | 18 | 0.100 |
Why?
|
| Transcription, Genetic | 1 | 2017 | 1115 | 0.100 |
Why?
|
| Lung | 1 | 2020 | 1365 | 0.100 |
Why?
|
| Rectal Neoplasms | 1 | 2014 | 132 | 0.090 |
Why?
|
| Capsaicin | 1 | 2012 | 43 | 0.090 |
Why?
|
| Sodium-Potassium-Chloride Symporters | 1 | 2012 | 22 | 0.090 |
Why?
|
| TRPV Cation Channels | 1 | 2012 | 16 | 0.090 |
Why?
|
| Homeodomain Proteins | 1 | 2016 | 556 | 0.090 |
Why?
|
| Up-Regulation | 3 | 2013 | 729 | 0.090 |
Why?
|
| Microbiota | 2 | 2016 | 425 | 0.090 |
Why?
|
| Adolescent | 6 | 2021 | 9610 | 0.090 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2014 | 156 | 0.090 |
Why?
|
| Trinitrobenzenesulfonic Acid | 1 | 2012 | 16 | 0.090 |
Why?
|
| Bacteria | 1 | 2016 | 509 | 0.090 |
Why?
|
| Chlorides | 1 | 2012 | 100 | 0.090 |
Why?
|
| Ileum | 2 | 2025 | 167 | 0.090 |
Why?
|
| Neoplasm Proteins | 2 | 2013 | 538 | 0.090 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2012 | 58 | 0.090 |
Why?
|
| Klebsiella Infections | 1 | 2012 | 32 | 0.090 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2013 | 82 | 0.090 |
Why?
|
| Lipopolysaccharides | 2 | 2015 | 300 | 0.090 |
Why?
|
| Nuclear Proteins | 1 | 2016 | 740 | 0.090 |
Why?
|
| Opportunistic Infections | 1 | 2012 | 57 | 0.090 |
Why?
|
| Klebsiella pneumoniae | 1 | 2012 | 35 | 0.090 |
Why?
|
| Interleukin-8 | 2 | 2009 | 88 | 0.090 |
Why?
|
| Lipid Metabolism | 1 | 2013 | 214 | 0.090 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2021 | 1339 | 0.090 |
Why?
|
| Carrier Proteins | 1 | 2015 | 660 | 0.090 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2011 | 24 | 0.090 |
Why?
|
| Genistein | 1 | 2011 | 16 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2021 | 2484 | 0.090 |
Why?
|
| Molecular Structure | 1 | 2012 | 306 | 0.090 |
Why?
|
| Bacterial Adhesion | 1 | 2011 | 83 | 0.090 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2012 | 111 | 0.090 |
Why?
|
| ErbB Receptors | 2 | 2012 | 506 | 0.080 |
Why?
|
| Heart Ventricles | 4 | 2003 | 650 | 0.080 |
Why?
|
| Electric Conductivity | 3 | 2012 | 142 | 0.080 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2014 | 481 | 0.080 |
Why?
|
| Aged, 80 and over | 4 | 2021 | 7073 | 0.080 |
Why?
|
| Heart Atria | 2 | 2024 | 248 | 0.080 |
Why?
|
| Enterocytes | 2 | 2025 | 27 | 0.080 |
Why?
|
| Biopsy | 3 | 2021 | 1177 | 0.080 |
Why?
|
| Mouth Neoplasms | 1 | 2012 | 202 | 0.080 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2012 | 288 | 0.080 |
Why?
|
| Electrophysiology | 3 | 2011 | 390 | 0.080 |
Why?
|
| Cytosol | 3 | 2010 | 192 | 0.080 |
Why?
|
| Microscopy, Electron | 2 | 2022 | 433 | 0.080 |
Why?
|
| Molecular Targeted Therapy | 1 | 2012 | 304 | 0.080 |
Why?
|
| Tissue Culture Techniques | 1 | 2010 | 81 | 0.080 |
Why?
|
| Molecular Dynamics Simulation | 2 | 2024 | 304 | 0.080 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2016 | 590 | 0.070 |
Why?
|
| Protein Transport | 4 | 2013 | 438 | 0.070 |
Why?
|
| Cell Movement | 2 | 2012 | 804 | 0.070 |
Why?
|
| Algorithms | 1 | 2017 | 1954 | 0.070 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2009 | 47 | 0.070 |
Why?
|
| Enzyme Activation | 1 | 2010 | 672 | 0.070 |
Why?
|
| Prospective Studies | 4 | 2018 | 4565 | 0.070 |
Why?
|
| C-Reactive Protein | 2 | 2020 | 204 | 0.070 |
Why?
|
| Plasmodium falciparum | 2 | 2020 | 55 | 0.070 |
Why?
|
| Biomarkers | 3 | 2021 | 1912 | 0.070 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 2 | 2021 | 18 | 0.070 |
Why?
|
| T Cell Transcription Factor 1 | 2 | 2021 | 23 | 0.070 |
Why?
|
| Recombinant Proteins | 1 | 2010 | 982 | 0.070 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 2 | 2021 | 80 | 0.070 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 3 | 2013 | 35 | 0.070 |
Why?
|
| Stem Cells | 1 | 2010 | 386 | 0.070 |
Why?
|
| Cytoskeleton | 1 | 2009 | 198 | 0.070 |
Why?
|
| Matrix Metalloproteinases, Membrane-Associated | 1 | 2007 | 4 | 0.070 |
Why?
|
| Genome-Wide Association Study | 3 | 2021 | 1762 | 0.060 |
Why?
|
| Membrane Potentials | 3 | 2002 | 405 | 0.060 |
Why?
|
| Germ-Free Life | 2 | 2018 | 83 | 0.060 |
Why?
|
| Shab Potassium Channels | 1 | 2006 | 20 | 0.060 |
Why?
|
| Calcium-Transporting ATPases | 3 | 2003 | 27 | 0.060 |
Why?
|
| Arachidonic Acid | 1 | 2006 | 62 | 0.060 |
Why?
|
| Base Sequence | 1 | 2010 | 2209 | 0.060 |
Why?
|
| NF-kappa B | 2 | 2023 | 408 | 0.060 |
Why?
|
| HT29 Cells | 3 | 2011 | 49 | 0.060 |
Why?
|
| Multivariate Analysis | 2 | 2018 | 990 | 0.060 |
Why?
|
| Rats | 3 | 2023 | 4042 | 0.060 |
Why?
|
| Proof of Concept Study | 1 | 2025 | 56 | 0.060 |
Why?
|
| Endoscopy | 2 | 2020 | 366 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2011 | 364 | 0.050 |
Why?
|
| Interferon-gamma | 1 | 2007 | 460 | 0.050 |
Why?
|
| Phenotype | 2 | 2022 | 2543 | 0.050 |
Why?
|
| Nickel | 2 | 2002 | 14 | 0.050 |
Why?
|
| Logistic Models | 2 | 2018 | 1246 | 0.050 |
Why?
|
| Feces | 2 | 2016 | 360 | 0.050 |
Why?
|
| Claudin-3 | 1 | 2024 | 3 | 0.050 |
Why?
|
| Phenylmercury Compounds | 1 | 2023 | 2 | 0.050 |
Why?
|
| Oxadiazoles | 1 | 2024 | 37 | 0.050 |
Why?
|
| GATA4 Transcription Factor | 1 | 2024 | 19 | 0.050 |
Why?
|
| RNA, Messenger | 1 | 2010 | 2020 | 0.050 |
Why?
|
| Epoxy Compounds | 1 | 2023 | 10 | 0.050 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2023 | 26 | 0.050 |
Why?
|
| Chemoprevention | 2 | 2015 | 93 | 0.050 |
Why?
|
| Ferrets | 2 | 2001 | 49 | 0.050 |
Why?
|
| Tumor Necrosis Factor alpha-Induced Protein 3 | 2 | 2014 | 17 | 0.050 |
Why?
|
| Delphi Technique | 1 | 2024 | 136 | 0.050 |
Why?
|
| Pancreatitis-Associated Proteins | 2 | 2014 | 18 | 0.050 |
Why?
|
| Islets of Langerhans | 1 | 2006 | 557 | 0.050 |
Why?
|
| Immunohistochemistry | 2 | 2021 | 1790 | 0.050 |
Why?
|
| Ions | 1 | 2003 | 78 | 0.050 |
Why?
|
| Freeze Fracturing | 1 | 2022 | 11 | 0.050 |
Why?
|
| Arginine | 1 | 2023 | 140 | 0.050 |
Why?
|
| Models, Animal | 2 | 2015 | 281 | 0.050 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2019 | 454 | 0.050 |
Why?
|
| Colonoscopy | 2 | 2018 | 303 | 0.050 |
Why?
|
| Intracellular Fluid | 1 | 2002 | 32 | 0.050 |
Why?
|
| Ligands | 1 | 2023 | 476 | 0.050 |
Why?
|
| Amino Acids | 1 | 2023 | 246 | 0.050 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2022 | 98 | 0.040 |
Why?
|
| Indoles | 1 | 2023 | 301 | 0.040 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2002 | 88 | 0.040 |
Why?
|
| Receptors, Notch | 1 | 2022 | 138 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2008 | 3061 | 0.040 |
Why?
|
| Gastroscopy | 1 | 2021 | 25 | 0.040 |
Why?
|
| Blotting, Western | 2 | 2012 | 775 | 0.040 |
Why?
|
| Interferon Regulatory Factors | 1 | 2021 | 75 | 0.040 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2014 | 457 | 0.040 |
Why?
|
| Mutagenesis | 1 | 2001 | 192 | 0.040 |
Why?
|
| Research Design | 1 | 2024 | 620 | 0.040 |
Why?
|
| Automation | 1 | 2020 | 105 | 0.040 |
Why?
|
| MAP Kinase Kinase Kinase 3 | 1 | 2020 | 13 | 0.040 |
Why?
|
| Injections | 1 | 2020 | 124 | 0.040 |
Why?
|
| Endothelium | 1 | 2020 | 59 | 0.040 |
Why?
|
| Cell Culture Techniques | 1 | 2020 | 196 | 0.040 |
Why?
|
| Cell Cycle | 2 | 2012 | 515 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 367 | 0.040 |
Why?
|
| Binding Sites | 2 | 2014 | 1128 | 0.040 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2020 | 87 | 0.040 |
Why?
|
| Enzyme Inhibitors | 1 | 2022 | 639 | 0.040 |
Why?
|
| Heart | 2 | 2017 | 522 | 0.040 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2019 | 42 | 0.040 |
Why?
|
| Tumor Microenvironment | 1 | 2023 | 554 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2021 | 1102 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 2 | 2013 | 959 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2022 | 537 | 0.040 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2019 | 61 | 0.040 |
Why?
|
| Tumor Necrosis Factors | 1 | 2018 | 14 | 0.040 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2018 | 41 | 0.030 |
Why?
|
| Lactobacillus | 1 | 2018 | 23 | 0.030 |
Why?
|
| Thapsigargin | 1 | 1998 | 55 | 0.030 |
Why?
|
| Isoproterenol | 1 | 1998 | 57 | 0.030 |
Why?
|
| Penetrance | 1 | 2018 | 48 | 0.030 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2018 | 36 | 0.030 |
Why?
|
| Acinar Cells | 1 | 2017 | 8 | 0.030 |
Why?
|
| Dioxygenases | 1 | 2018 | 82 | 0.030 |
Why?
|
| Genomics | 1 | 2024 | 848 | 0.030 |
Why?
|
| Nitriles | 1 | 2018 | 154 | 0.030 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 178 | 0.030 |
Why?
|
| Biological Therapy | 1 | 2018 | 46 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2018 | 101 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 2019 | 543 | 0.030 |
Why?
|
| Histocytochemistry | 1 | 2017 | 123 | 0.030 |
Why?
|
| Cardiotonic Agents | 1 | 1998 | 88 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2018 | 304 | 0.030 |
Why?
|
| Endoscopy, Digestive System | 1 | 2017 | 72 | 0.030 |
Why?
|
| Cyclosporine | 1 | 2018 | 241 | 0.030 |
Why?
|
| Periodicity | 1 | 2017 | 113 | 0.030 |
Why?
|
| Tacrolimus | 1 | 2018 | 372 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2018 | 276 | 0.030 |
Why?
|
| Actin Cytoskeleton | 1 | 2018 | 196 | 0.030 |
Why?
|
| Atrial Function | 1 | 2016 | 16 | 0.030 |
Why?
|
| Parasite Egg Count | 1 | 2016 | 7 | 0.030 |
Why?
|
| Bacterial Infections | 1 | 2018 | 179 | 0.030 |
Why?
|
| Cytochromes b | 1 | 2016 | 12 | 0.030 |
Why?
|
| Oocysts | 1 | 2016 | 8 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2021 | 1715 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2018 | 829 | 0.030 |
Why?
|
| Anemia | 1 | 2017 | 134 | 0.030 |
Why?
|
| Cats | 1 | 2016 | 285 | 0.030 |
Why?
|
| Haploinsufficiency | 1 | 2016 | 69 | 0.030 |
Why?
|
| Remission Induction | 1 | 2018 | 738 | 0.030 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2018 | 202 | 0.030 |
Why?
|
| Fecal Microbiota Transplantation | 1 | 2016 | 80 | 0.030 |
Why?
|
| Piroxicam | 1 | 2015 | 11 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2018 | 384 | 0.030 |
Why?
|
| Drug Resistance | 1 | 2016 | 233 | 0.030 |
Why?
|
| Dinoprostone | 1 | 2015 | 71 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2022 | 1449 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2016 | 221 | 0.030 |
Why?
|
| Protective Agents | 1 | 2015 | 34 | 0.030 |
Why?
|
| Anniversaries and Special Events | 1 | 2015 | 16 | 0.030 |
Why?
|
| Adoptive Transfer | 1 | 2015 | 173 | 0.030 |
Why?
|
| Autophagy-Related Proteins | 1 | 2015 | 23 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2017 | 702 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 2718 | 0.030 |
Why?
|
| Rectum | 1 | 2015 | 149 | 0.030 |
Why?
|
| Ribonuclease, Pancreatic | 1 | 2014 | 24 | 0.030 |
Why?
|
| Glucuronosyltransferase | 1 | 2015 | 178 | 0.030 |
Why?
|
| Lectins, C-Type | 1 | 2014 | 71 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2018 | 1923 | 0.030 |
Why?
|
| Genes, APC | 1 | 2014 | 25 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2021 | 3832 | 0.030 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2014 | 79 | 0.030 |
Why?
|
| Perilipin-2 | 1 | 2013 | 2 | 0.020 |
Why?
|
| Chicago | 1 | 2018 | 1464 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2014 | 351 | 0.020 |
Why?
|
| Chromatin | 1 | 2016 | 440 | 0.020 |
Why?
|
| Th17 Cells | 1 | 2014 | 93 | 0.020 |
Why?
|
| Solute Carrier Family 12, Member 2 | 1 | 2012 | 16 | 0.020 |
Why?
|
| Colforsin | 1 | 2012 | 68 | 0.020 |
Why?
|
| Biotinylation | 1 | 2012 | 42 | 0.020 |
Why?
|
| Acrylamides | 1 | 2012 | 34 | 0.020 |
Why?
|
| Time Factors | 2 | 2012 | 5406 | 0.020 |
Why?
|
| 4-Nitroquinoline-1-oxide | 1 | 2012 | 15 | 0.020 |
Why?
|
| Antigens, Neoplasm | 1 | 2014 | 356 | 0.020 |
Why?
|
| Mucin-2 | 1 | 2012 | 12 | 0.020 |
Why?
|
| Receptors, Polymeric Immunoglobulin | 1 | 2012 | 5 | 0.020 |
Why?
|
| Administration, Topical | 1 | 2012 | 80 | 0.020 |
Why?
|
| Rats, Inbred F344 | 1 | 2012 | 160 | 0.020 |
Why?
|
| Cyclin D1 | 1 | 2012 | 85 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2012 | 76 | 0.020 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2012 | 98 | 0.020 |
Why?
|
| Mouth Mucosa | 1 | 2012 | 71 | 0.020 |
Why?
|
| Sirtuins | 1 | 2013 | 79 | 0.020 |
Why?
|
| Incidence | 1 | 2016 | 1702 | 0.020 |
Why?
|
| Immunity, Mucosal | 1 | 2012 | 71 | 0.020 |
Why?
|
| Integrin beta1 | 1 | 2011 | 34 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2013 | 519 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2015 | 1731 | 0.020 |
Why?
|
| Intracellular Space | 1 | 2011 | 38 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2015 | 1525 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2012 | 309 | 0.020 |
Why?
|
| Metagenome | 1 | 2012 | 116 | 0.020 |
Why?
|
| Dopamine | 1 | 2012 | 276 | 0.020 |
Why?
|
| HCT116 Cells | 1 | 2011 | 162 | 0.020 |
Why?
|
| Genotype | 1 | 2015 | 1866 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2013 | 246 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 885 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2012 | 657 | 0.020 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2011 | 86 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2012 | 469 | 0.020 |
Why?
|
| Child | 1 | 2021 | 7359 | 0.020 |
Why?
|
| Wnt Proteins | 1 | 2010 | 127 | 0.020 |
Why?
|
| I-kappa B Kinase | 1 | 2009 | 41 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2009 | 177 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2012 | 1913 | 0.020 |
Why?
|
| Fluorescence Recovery After Photobleaching | 1 | 2008 | 12 | 0.020 |
Why?
|
| Diffusion | 1 | 2008 | 90 | 0.020 |
Why?
|
| Disease Progression | 1 | 2012 | 1531 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 3835 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2008 | 106 | 0.020 |
Why?
|
| Glycosylphosphatidylinositols | 1 | 2007 | 9 | 0.020 |
Why?
|
| Mutation | 1 | 2019 | 4266 | 0.020 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2007 | 18 | 0.020 |
Why?
|
| Cell Polarity | 1 | 2008 | 118 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 2465 | 0.020 |
Why?
|
| GPI-Linked Proteins | 1 | 2007 | 55 | 0.020 |
Why?
|
| Haplorhini | 1 | 2007 | 77 | 0.020 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-2 | 1 | 2007 | 24 | 0.020 |
Why?
|
| Carbachol | 1 | 2006 | 35 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2009 | 602 | 0.020 |
Why?
|
| Phospholipases A | 1 | 2006 | 45 | 0.020 |
Why?
|
| Intestine, Small | 1 | 2009 | 310 | 0.020 |
Why?
|
| Catalytic Domain | 1 | 2007 | 162 | 0.020 |
Why?
|
| Proteins | 1 | 2012 | 800 | 0.020 |
Why?
|
| Infant | 1 | 2013 | 3222 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2007 | 215 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2010 | 603 | 0.010 |
Why?
|
| Cell Division | 1 | 2007 | 690 | 0.010 |
Why?
|
| Transfection | 1 | 2007 | 878 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2018 | 9108 | 0.010 |
Why?
|
| Computational Biology | 1 | 2008 | 578 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2007 | 1993 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2010 | 1275 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2007 | 2889 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 2002 | 162 | 0.010 |
Why?
|
| Strophanthidin | 1 | 2002 | 3 | 0.010 |
Why?
|
| Sodium Channel Blockers | 1 | 2002 | 26 | 0.010 |
Why?
|
| Tetrodotoxin | 1 | 2002 | 49 | 0.010 |
Why?
|
| Diastole | 1 | 2002 | 99 | 0.010 |
Why?
|
| Sodium Channels | 1 | 2002 | 130 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 2002 | 344 | 0.010 |
Why?
|